ClinicalTrials.gg
Drug

Pregabalin clinical trials

Also written Lyrica, Lyrica 150mg and YHD1119.

studies test it
390
open now
33
in phase 3
120
first study started
1997

How each study uses Pregabalin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Pregabalin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Dec 2004 · LYRICA · NDA 021446 (FDA, Drugs@FDA)
European Union
5 Jul 2004 · Lyrica · EMEA/H/C/000546 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pregabalin
259
Pregabalin 150mg
30
pregabalin (Lyrica)
14
Pregabalin 75mg
12
Pregabalin 300mg
9

Brand

Lyrica
88
Lyrica 150mg
4
Lyrica 300 mg
1

Development codes

YHD1119
3
CI-1008
1
PD-144723
1

In one entry with another drug

Given together, or one or the other

S-ketamine and pregabalin
3

Studies by the year they started

388 studies that test it; most in 2011 (28)

Studies that test Pregabalin, by start year
YearStudies
19971
19982
19992
20014
20024
20047
200518
200627
200725
200827
200922
201021
201128
201218
201311
201415
201517
201612
201711
201817
201914
202012
202116
202215
202311
20249
20259
202613

By phase

A phase 1/2 study counts in both.

Early Phase 1
10
Phase 1
33
Phase 2
60
Phase 3
120
Phase 4
119
No phase
68

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 139 · Other 251

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (86) · Pfizer (18) · Beijing Tiantan Hospital (12) · Cairo University (6) · Yuhan Corporation (6) · Tel-Aviv Sourasky Medical Center (5) · Rambam Health Care Campus (4) · Mansoura University (4)

Often tested with

Tested in the same studies.

Duloxetine (19) · Acetaminophen (10) · Gabapentin (9) · Celecoxib (8) · Dexmedetomidine (5) · Tramadol (4) · Oxycodone (4) · Melatonin (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Pregabalin is the comparator. A study of two new drugs counts under both.

  • 1Suzetrigine · Vertex Pharmaceuticals Incorporated · next primary completion May 2027
Reaching primary completion within a year · 13, 1 in phase 3

Studies that test Pregabalin, phase 3 first.

Studies

Open first, then newest update. How each study uses Pregabalin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 390

See all 390 studies that test Pregabalin →

Given beside what is tested · 10 — Pregabalin is usual care or a partner of the new treatment
As the comparator · 65 — what is tested is compared with Pregabalin

Showing 20 of 65.

What changed recently

From the registry's own updates since Oct 15, 2026.

Codes

What other systems call Pregabalin · ClinicalTrials.gg INT006615

  • MeSH (NLM) D000069583PregabalinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 55JG375S6MPREGABALINConfirmed FDA, NLM, Wikidata
  • RxNorm 187832Confirmed FDA, Wikidata
  • Wikidata Q412174pregabalinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C64625PregabalinOne source FDA
  • DrugBank DB00230One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.